nodes	percent_of_prediction	percent_of_DWPC	metapath
Bedaquiline—CYP3A4—prostate cancer	0.344	1	CbGaD
Bedaquiline—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.101	0.207	CbGbCtD
Bedaquiline—CYP3A4—Bicalutamide—prostate cancer	0.0528	0.109	CbGbCtD
Bedaquiline—CYP3A4—Estramustine—prostate cancer	0.0491	0.101	CbGbCtD
Bedaquiline—CYP3A4—Abiraterone—prostate cancer	0.0438	0.09	CbGbCtD
Bedaquiline—CYP3A4—Flutamide—prostate cancer	0.0438	0.09	CbGbCtD
Bedaquiline—CYP3A4—Cabazitaxel—prostate cancer	0.0324	0.0666	CbGbCtD
Bedaquiline—CYP3A4—Estrone—prostate cancer	0.0316	0.0651	CbGbCtD
Bedaquiline—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0282	0.058	CbGbCtD
Bedaquiline—CYP3A4—Conjugated Estrogens—prostate cancer	0.0207	0.0426	CbGbCtD
Bedaquiline—CYP3A4—Mitoxantrone—prostate cancer	0.0188	0.0387	CbGbCtD
Bedaquiline—CYP3A4—Estradiol—prostate cancer	0.0182	0.0374	CbGbCtD
Bedaquiline—CYP3A4—Prednisone—prostate cancer	0.0156	0.0321	CbGbCtD
Bedaquiline—CYP3A4—Etoposide—prostate cancer	0.0119	0.0244	CbGbCtD
Bedaquiline—CYP3A4—Docetaxel—prostate cancer	0.0109	0.0223	CbGbCtD
Bedaquiline—CYP3A4—Doxorubicin—prostate cancer	0.00809	0.0166	CbGbCtD
Bedaquiline—Tamoxifen—SULT1A1—prostate cancer	0.000851	0.21	CrCbGaD
Bedaquiline—Vomiting—Estrone—prostate cancer	0.000449	0.00325	CcSEcCtD
Bedaquiline—Diarrhoea—Nilutamide—prostate cancer	0.000448	0.00325	CcSEcCtD
Bedaquiline—Diarrhoea—Flutamide—prostate cancer	0.000446	0.00323	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Mitoxantrone—prostate cancer	0.000445	0.00323	CcSEcCtD
Bedaquiline—Rash—Estrone—prostate cancer	0.000445	0.00322	CcSEcCtD
Bedaquiline—Dermatitis—Estrone—prostate cancer	0.000444	0.00322	CcSEcCtD
Bedaquiline—Headache—Estrone—prostate cancer	0.000442	0.0032	CcSEcCtD
Bedaquiline—Nausea—Estramustine—prostate cancer	0.000439	0.00318	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Mitoxantrone—prostate cancer	0.000436	0.00316	CcSEcCtD
Bedaquiline—Dizziness—Nilutamide—prostate cancer	0.000433	0.00314	CcSEcCtD
Bedaquiline—Dizziness—Flutamide—prostate cancer	0.000431	0.00313	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Bicalutamide—prostate cancer	0.000431	0.00312	CcSEcCtD
Bedaquiline—Cardiac disorder—Goserelin—prostate cancer	0.00043	0.00311	CcSEcCtD
Bedaquiline—Haemoptysis—Epirubicin—prostate cancer	0.000429	0.00311	CcSEcCtD
Bedaquiline—Cardiac disorder—Conjugated Estrogens—prostate cancer	0.000426	0.00308	CcSEcCtD
Bedaquiline—Nausea—Estrone—prostate cancer	0.000419	0.00304	CcSEcCtD
Bedaquiline—Vomiting—Nilutamide—prostate cancer	0.000417	0.00302	CcSEcCtD
Bedaquiline—Vomiting—Flutamide—prostate cancer	0.000415	0.003	CcSEcCtD
Bedaquiline—Arrhythmia—Goserelin—prostate cancer	0.000414	0.003	CcSEcCtD
Bedaquiline—Rash—Nilutamide—prostate cancer	0.000413	0.00299	CcSEcCtD
Bedaquiline—Dermatitis—Nilutamide—prostate cancer	0.000413	0.00299	CcSEcCtD
Bedaquiline—Rash—Flutamide—prostate cancer	0.000411	0.00298	CcSEcCtD
Bedaquiline—Decreased appetite—Bicalutamide—prostate cancer	0.000411	0.00298	CcSEcCtD
Bedaquiline—Dermatitis—Flutamide—prostate cancer	0.000411	0.00298	CcSEcCtD
Bedaquiline—Headache—Nilutamide—prostate cancer	0.00041	0.00297	CcSEcCtD
Bedaquiline—Arrhythmia—Conjugated Estrogens—prostate cancer	0.00041	0.00297	CcSEcCtD
Bedaquiline—Headache—Flutamide—prostate cancer	0.000409	0.00296	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.000408	0.00296	CcSEcCtD
Bedaquiline—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000407	0.00295	CcSEcCtD
Bedaquiline—Diarrhoea—Degarelix—prostate cancer	0.0004	0.0029	CcSEcCtD
Bedaquiline—Haemoptysis—Doxorubicin—prostate cancer	0.000397	0.00288	CcSEcCtD
Bedaquiline—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000392	0.00284	CcSEcCtD
Bedaquiline—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000391	0.00284	CcSEcCtD
Bedaquiline—Nausea—Nilutamide—prostate cancer	0.000389	0.00282	CcSEcCtD
Bedaquiline—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000388	0.00281	CcSEcCtD
Bedaquiline—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000388	0.00281	CcSEcCtD
Bedaquiline—Nausea—Flutamide—prostate cancer	0.000387	0.00281	CcSEcCtD
Bedaquiline—Dizziness—Degarelix—prostate cancer	0.000387	0.0028	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Estradiol—prostate cancer	0.000387	0.0028	CcSEcCtD
Bedaquiline—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000386	0.00279	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Capecitabine—prostate cancer	0.000379	0.00274	CcSEcCtD
Bedaquiline—Diarrhoea—Cabazitaxel—prostate cancer	0.000377	0.00273	CcSEcCtD
Bedaquiline—Vomiting—Degarelix—prostate cancer	0.000372	0.0027	CcSEcCtD
Bedaquiline—Toremifene—ESR1—prostate cancer	0.000369	0.0913	CrCbGaD
Bedaquiline—Rash—Degarelix—prostate cancer	0.000369	0.00267	CcSEcCtD
Bedaquiline—Dermatitis—Degarelix—prostate cancer	0.000369	0.00267	CcSEcCtD
Bedaquiline—Hepatitis—Estradiol—prostate cancer	0.000367	0.00266	CcSEcCtD
Bedaquiline—Headache—Degarelix—prostate cancer	0.000367	0.00266	CcSEcCtD
Bedaquiline—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000366	0.00265	CcSEcCtD
Bedaquiline—Dizziness—Cabazitaxel—prostate cancer	0.000365	0.00264	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Etoposide—prostate cancer	0.000363	0.00263	CcSEcCtD
Bedaquiline—Connective tissue disorder—Estradiol—prostate cancer	0.000361	0.00261	CcSEcCtD
Bedaquiline—Vomiting—Cabazitaxel—prostate cancer	0.000351	0.00254	CcSEcCtD
Bedaquiline—Nausea—Degarelix—prostate cancer	0.000348	0.00252	CcSEcCtD
Bedaquiline—Headache—Cabazitaxel—prostate cancer	0.000345	0.0025	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000345	0.0025	CcSEcCtD
Bedaquiline—Chest pain—Goserelin—prostate cancer	0.000343	0.00249	CcSEcCtD
Bedaquiline—Arthralgia—Goserelin—prostate cancer	0.000343	0.00249	CcSEcCtD
Bedaquiline—Myalgia—Goserelin—prostate cancer	0.000343	0.00249	CcSEcCtD
Bedaquiline—Hepatitis—Mitoxantrone—prostate cancer	0.000342	0.00248	CcSEcCtD
Bedaquiline—Cardiac disorder—Estradiol—prostate cancer	0.000341	0.00247	CcSEcCtD
Bedaquiline—Myalgia—Conjugated Estrogens—prostate cancer	0.00034	0.00246	CcSEcCtD
Bedaquiline—Arthralgia—Conjugated Estrogens—prostate cancer	0.00034	0.00246	CcSEcCtD
Bedaquiline—Chest pain—Conjugated Estrogens—prostate cancer	0.00034	0.00246	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Capecitabine—prostate cancer	0.000338	0.00245	CcSEcCtD
Bedaquiline—Nausea—Cabazitaxel—prostate cancer	0.000328	0.00237	CcSEcCtD
Bedaquiline—Diarrhoea—Bicalutamide—prostate cancer	0.000324	0.00234	CcSEcCtD
Bedaquiline—Nervous system disorder—Goserelin—prostate cancer	0.000323	0.00234	CcSEcCtD
Bedaquiline—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.00032	0.00232	CcSEcCtD
Bedaquiline—Anorexia—Goserelin—prostate cancer	0.000314	0.00227	CcSEcCtD
Bedaquiline—Dizziness—Bicalutamide—prostate cancer	0.000313	0.00227	CcSEcCtD
Bedaquiline—Anorexia—Conjugated Estrogens—prostate cancer	0.000311	0.00225	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Docetaxel—prostate cancer	0.000308	0.00223	CcSEcCtD
Bedaquiline—Arrhythmia—Mitoxantrone—prostate cancer	0.000306	0.00221	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Docetaxel—prostate cancer	0.000301	0.00218	CcSEcCtD
Bedaquiline—Vomiting—Bicalutamide—prostate cancer	0.000301	0.00218	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Etoposide—prostate cancer	0.0003	0.00217	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Goserelin—prostate cancer	0.0003	0.00217	CcSEcCtD
Bedaquiline—Rash—Bicalutamide—prostate cancer	0.000298	0.00216	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Capecitabine—prostate cancer	0.000298	0.00216	CcSEcCtD
Bedaquiline—Dermatitis—Bicalutamide—prostate cancer	0.000298	0.00216	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000297	0.00215	CcSEcCtD
Bedaquiline—Headache—Bicalutamide—prostate cancer	0.000296	0.00215	CcSEcCtD
Bedaquiline—Toremifene—CYP1A1—prostate cancer	0.000295	0.073	CrCbGaD
Bedaquiline—Alanine aminotransferase increased—Capecitabine—prostate cancer	0.000292	0.00211	CcSEcCtD
Bedaquiline—Decreased appetite—Goserelin—prostate cancer	0.000286	0.00207	CcSEcCtD
Bedaquiline—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000283	0.00205	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000281	0.00204	CcSEcCtD
Bedaquiline—Nausea—Bicalutamide—prostate cancer	0.000281	0.00204	CcSEcCtD
Bedaquiline—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—prostate cancer	0.000281	0.0101	CbGpPWpGaD
Bedaquiline—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—prostate cancer	0.000277	0.00995	CbGpPWpGaD
Bedaquiline—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000274	0.00198	CcSEcCtD
Bedaquiline—Chest pain—Estradiol—prostate cancer	0.000272	0.00197	CcSEcCtD
Bedaquiline—Myalgia—Estradiol—prostate cancer	0.000272	0.00197	CcSEcCtD
Bedaquiline—Arthralgia—Estradiol—prostate cancer	0.000272	0.00197	CcSEcCtD
Bedaquiline—Diphenhydramine—CYP2C18—prostate cancer	0.000271	0.067	CrCbGaD
Bedaquiline—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—prostate cancer	0.000268	0.00963	CbGpPWpGaD
Bedaquiline—Dizziness—Ethinyl Estradiol—prostate cancer	0.000264	0.00192	CcSEcCtD
Bedaquiline—Cardiac disorder—Etoposide—prostate cancer	0.000264	0.00191	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Epirubicin—prostate cancer	0.000264	0.00191	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Prednisone—prostate cancer	0.00026	0.00188	CcSEcCtD
Bedaquiline—CYP3A4—Tamoxifen metabolism—SULT2A1—prostate cancer	0.000259	0.00931	CbGpPWpGaD
Bedaquiline—Nervous system disorder—Estradiol—prostate cancer	0.000256	0.00185	CcSEcCtD
Bedaquiline—Vomiting—Ethinyl Estradiol—prostate cancer	0.000254	0.00184	CcSEcCtD
Bedaquiline—Chest pain—Mitoxantrone—prostate cancer	0.000254	0.00184	CcSEcCtD
Bedaquiline—Arthralgia—Mitoxantrone—prostate cancer	0.000254	0.00184	CcSEcCtD
Bedaquiline—Myalgia—Mitoxantrone—prostate cancer	0.000254	0.00184	CcSEcCtD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—CYP3A5—prostate cancer	0.000253	0.00908	CbGpPWpGaD
Bedaquiline—Rash—Ethinyl Estradiol—prostate cancer	0.000252	0.00183	CcSEcCtD
Bedaquiline—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000252	0.00182	CcSEcCtD
Bedaquiline—Headache—Ethinyl Estradiol—prostate cancer	0.00025	0.00181	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Docetaxel—prostate cancer	0.000249	0.00181	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Doxorubicin—prostate cancer	0.000244	0.00177	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Capecitabine—prostate cancer	0.000241	0.00175	CcSEcCtD
Bedaquiline—CYP3A4—Xenobiotics—CYP2C19—prostate cancer	0.00024	0.00862	CbGpPWpGaD
Bedaquiline—Tamoxifen—ESR2—prostate cancer	0.000239	0.0592	CrCbGaD
Bedaquiline—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000238	0.00172	CcSEcCtD
Bedaquiline—Nausea—Ethinyl Estradiol—prostate cancer	0.000237	0.00172	CcSEcCtD
Bedaquiline—Hepatitis—Docetaxel—prostate cancer	0.000236	0.00171	CcSEcCtD
Bedaquiline—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—prostate cancer	0.000235	0.00846	CbGpPWpGaD
Bedaquiline—Cerebrovascular accident—Epirubicin—prostate cancer	0.000235	0.0017	CcSEcCtD
Bedaquiline—Connective tissue disorder—Docetaxel—prostate cancer	0.000232	0.00168	CcSEcCtD
Bedaquiline—Anorexia—Mitoxantrone—prostate cancer	0.000232	0.00168	CcSEcCtD
Bedaquiline—CYP3A4—Xenobiotics—CYP2A6—prostate cancer	0.000232	0.00832	CbGpPWpGaD
Bedaquiline—CYP3A4—Tamoxifen metabolism—CYP2C19—prostate cancer	0.000231	0.00829	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A43—prostate cancer	0.000229	0.00823	CbGpPWpGaD
Bedaquiline—Hepatitis—Capecitabine—prostate cancer	0.000229	0.00166	CcSEcCtD
Bedaquiline—Decreased appetite—Estradiol—prostate cancer	0.000227	0.00164	CcSEcCtD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP3A43—prostate cancer	0.000226	0.00812	CbGpPWpGaD
Bedaquiline—Gastrointestinal disorder—Estradiol—prostate cancer	0.000225	0.00163	CcSEcCtD
Bedaquiline—Diarrhoea—Goserelin—prostate cancer	0.000225	0.00163	CcSEcCtD
Bedaquiline—Connective tissue disorder—Capecitabine—prostate cancer	0.000225	0.00163	CcSEcCtD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTK1—prostate cancer	0.000224	0.00803	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTCD—prostate cancer	0.000224	0.00803	CbGpPWpGaD
Bedaquiline—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000223	0.00162	CcSEcCtD
Bedaquiline—CYP3A4—Tamoxifen metabolism—CYP2A6—prostate cancer	0.000223	0.008	CbGpPWpGaD
Bedaquiline—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000221	0.0016	CcSEcCtD
Bedaquiline—Diphenhydramine—SLC22A1—prostate cancer	0.000221	0.0547	CrCbGaD
Bedaquiline—CYP3A4—Tryptophan metabolism—CYP7B1—prostate cancer	0.00022	0.00791	CbGpPWpGaD
Bedaquiline—Cardiac disorder—Docetaxel—prostate cancer	0.000219	0.00159	CcSEcCtD
Bedaquiline—Tamoxifen—CYP1B1—prostate cancer	0.000218	0.054	CrCbGaD
Bedaquiline—Cerebrovascular accident—Doxorubicin—prostate cancer	0.000218	0.00158	CcSEcCtD
Bedaquiline—Dizziness—Goserelin—prostate cancer	0.000218	0.00158	CcSEcCtD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—prostate cancer	0.000218	0.00781	CbGpPWpGaD
Bedaquiline—Dizziness—Conjugated Estrogens—prostate cancer	0.000216	0.00156	CcSEcCtD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—prostate cancer	0.000215	0.00772	CbGpPWpGaD
Bedaquiline—Cardiac disorder—Capecitabine—prostate cancer	0.000212	0.00154	CcSEcCtD
Bedaquiline—CYP3A4—Estrogen metabolism—NQO1—prostate cancer	0.000212	0.00761	CbGpPWpGaD
Bedaquiline—Decreased appetite—Mitoxantrone—prostate cancer	0.000211	0.00153	CcSEcCtD
Bedaquiline—Arrhythmia—Docetaxel—prostate cancer	0.000211	0.00153	CcSEcCtD
Bedaquiline—Chest pain—Etoposide—prostate cancer	0.000211	0.00153	CcSEcCtD
Bedaquiline—Vomiting—Goserelin—prostate cancer	0.000209	0.00152	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Epirubicin—prostate cancer	0.000208	0.0015	CcSEcCtD
Bedaquiline—Rash—Goserelin—prostate cancer	0.000207	0.0015	CcSEcCtD
Bedaquiline—Dermatitis—Goserelin—prostate cancer	0.000207	0.0015	CcSEcCtD
Bedaquiline—Vomiting—Conjugated Estrogens—prostate cancer	0.000207	0.0015	CcSEcCtD
Bedaquiline—Headache—Goserelin—prostate cancer	0.000206	0.00149	CcSEcCtD
Bedaquiline—Rash—Conjugated Estrogens—prostate cancer	0.000205	0.00149	CcSEcCtD
Bedaquiline—Dermatitis—Conjugated Estrogens—prostate cancer	0.000205	0.00149	CcSEcCtD
Bedaquiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—prostate cancer	0.000205	0.00735	CbGpPWpGaD
Bedaquiline—Arrhythmia—Capecitabine—prostate cancer	0.000205	0.00148	CcSEcCtD
Bedaquiline—Headache—Conjugated Estrogens—prostate cancer	0.000204	0.00148	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Epirubicin—prostate cancer	0.000203	0.00147	CcSEcCtD
Bedaquiline—CYP3A4—Estrogen metabolism—CYP1B1—prostate cancer	0.000203	0.0073	CbGpPWpGaD
Bedaquiline—Connective tissue disorder—Prednisone—prostate cancer	0.0002	0.00145	CcSEcCtD
Bedaquiline—CYP3A4—Xenobiotics—CYP2E1—prostate cancer	0.000197	0.00707	CbGpPWpGaD
Bedaquiline—Nausea—Goserelin—prostate cancer	0.000195	0.00142	CcSEcCtD
Bedaquiline—Nausea—Conjugated Estrogens—prostate cancer	0.000194	0.0014	CcSEcCtD
Bedaquiline—Anorexia—Etoposide—prostate cancer	0.000193	0.0014	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	0.000192	0.00139	CcSEcCtD
Bedaquiline—CYP3A4—Tamoxifen metabolism—CYP2E1—prostate cancer	0.000189	0.0068	CbGpPWpGaD
Bedaquiline—Toremifene—CYP3A4—prostate cancer	0.000189	0.0466	CrCbGaD
Bedaquiline—CYP3A4—Aflatoxin activation and detoxification—GGT1—prostate cancer	0.000188	0.00677	CbGpPWpGaD
Bedaquiline—Alanine aminotransferase increased—Doxorubicin—prostate cancer	0.000188	0.00136	CcSEcCtD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A43—prostate cancer	0.000186	0.00667	CbGpPWpGaD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—prostate cancer	0.000185	0.00664	CbGpPWpGaD
Bedaquiline—Arrhythmia—Prednisone—prostate cancer	0.000182	0.00132	CcSEcCtD
Bedaquiline—CYP3A4—Tamoxifen metabolism—CYP1B1—prostate cancer	0.00018	0.00645	CbGpPWpGaD
Bedaquiline—Diarrhoea—Estradiol—prostate cancer	0.000178	0.00129	CcSEcCtD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7B1—prostate cancer	0.000178	0.0064	CbGpPWpGaD
Bedaquiline—CYP3A4—Estrogen metabolism—COMT—prostate cancer	0.000178	0.00638	CbGpPWpGaD
Bedaquiline—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—prostate cancer	0.000177	0.00634	CbGpPWpGaD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP7B1—prostate cancer	0.000176	0.00631	CbGpPWpGaD
Bedaquiline—Decreased appetite—Etoposide—prostate cancer	0.000176	0.00127	CcSEcCtD
Bedaquiline—Myalgia—Docetaxel—prostate cancer	0.000175	0.00127	CcSEcCtD
Bedaquiline—Arthralgia—Docetaxel—prostate cancer	0.000175	0.00127	CcSEcCtD
Bedaquiline—Chest pain—Docetaxel—prostate cancer	0.000175	0.00127	CcSEcCtD
Bedaquiline—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—prostate cancer	0.000175	0.00628	CbGpPWpGaD
Bedaquiline—Gastrointestinal disorder—Etoposide—prostate cancer	0.000175	0.00126	CcSEcCtD
Bedaquiline—Tamoxifen—CYP3A5—prostate cancer	0.000174	0.043	CrCbGaD
Bedaquiline—Dizziness—Estradiol—prostate cancer	0.000172	0.00125	CcSEcCtD
Bedaquiline—Arthralgia—Capecitabine—prostate cancer	0.00017	0.00123	CcSEcCtD
Bedaquiline—Chest pain—Capecitabine—prostate cancer	0.00017	0.00123	CcSEcCtD
Bedaquiline—Myalgia—Capecitabine—prostate cancer	0.00017	0.00123	CcSEcCtD
Bedaquiline—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—prostate cancer	0.000169	0.00608	CbGpPWpGaD
Bedaquiline—Tamoxifen—CYP2A6—prostate cancer	0.000168	0.0416	CrCbGaD
Bedaquiline—Hepatobiliary disease—Epirubicin—prostate cancer	0.000168	0.00122	CcSEcCtD
Bedaquiline—Diarrhoea—Mitoxantrone—prostate cancer	0.000166	0.0012	CcSEcCtD
Bedaquiline—Vomiting—Estradiol—prostate cancer	0.000166	0.0012	CcSEcCtD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—prostate cancer	0.000165	0.00592	CbGpPWpGaD
Bedaquiline—Nervous system disorder—Docetaxel—prostate cancer	0.000165	0.00119	CcSEcCtD
Bedaquiline—Rash—Estradiol—prostate cancer	0.000164	0.00119	CcSEcCtD
Bedaquiline—Dermatitis—Estradiol—prostate cancer	0.000164	0.00119	CcSEcCtD
Bedaquiline—Headache—Estradiol—prostate cancer	0.000163	0.00118	CcSEcCtD
Bedaquiline—CYP3A4—Estrogen metabolism—GSTM1—prostate cancer	0.000162	0.00583	CbGpPWpGaD
Bedaquiline—Tamoxifen—CYP19A1—prostate cancer	0.00016	0.0396	CrCbGaD
Bedaquiline—Anorexia—Docetaxel—prostate cancer	0.00016	0.00116	CcSEcCtD
Bedaquiline—Nervous system disorder—Capecitabine—prostate cancer	0.00016	0.00116	CcSEcCtD
Bedaquiline—Hepatitis—Epirubicin—prostate cancer	0.00016	0.00116	CcSEcCtD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—prostate cancer	0.000159	0.00571	CbGpPWpGaD
Bedaquiline—Connective tissue disorder—Epirubicin—prostate cancer	0.000157	0.00114	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000155	0.00113	CcSEcCtD
Bedaquiline—Anorexia—Capecitabine—prostate cancer	0.000155	0.00112	CcSEcCtD
Bedaquiline—Nausea—Estradiol—prostate cancer	0.000155	0.00112	CcSEcCtD
Bedaquiline—Vomiting—Mitoxantrone—prostate cancer	0.000155	0.00112	CcSEcCtD
Bedaquiline—CYP3A4—Estrogen metabolism—CYP1A1—prostate cancer	0.000154	0.00553	CbGpPWpGaD
Bedaquiline—Rash—Mitoxantrone—prostate cancer	0.000153	0.00111	CcSEcCtD
Bedaquiline—Dermatitis—Mitoxantrone—prostate cancer	0.000153	0.00111	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000153	0.00111	CcSEcCtD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP3A5—prostate cancer	0.000153	0.00549	CbGpPWpGaD
Bedaquiline—Headache—Mitoxantrone—prostate cancer	0.000152	0.0011	CcSEcCtD
Bedaquiline—Myalgia—Prednisone—prostate cancer	0.000151	0.0011	CcSEcCtD
Bedaquiline—Arthralgia—Prednisone—prostate cancer	0.000151	0.0011	CcSEcCtD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP3A5—prostate cancer	0.000151	0.00542	CbGpPWpGaD
Bedaquiline—CYP3A4—Tryptophan metabolism—CYP2C18—prostate cancer	0.000149	0.00535	CbGpPWpGaD
Bedaquiline—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000148	0.00107	CcSEcCtD
Bedaquiline—Cardiac disorder—Epirubicin—prostate cancer	0.000148	0.00107	CcSEcCtD
Bedaquiline—Hepatitis—Doxorubicin—prostate cancer	0.000148	0.00107	CcSEcCtD
Bedaquiline—Tamoxifen—ESR1—prostate cancer	0.000148	0.0365	CrCbGaD
Bedaquiline—CYP3A4—Irinotecan Pathway—APC—prostate cancer	0.000147	0.0053	CbGpPWpGaD
Bedaquiline—Decreased appetite—Docetaxel—prostate cancer	0.000146	0.00106	CcSEcCtD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA2—prostate cancer	0.000145	0.00521	CbGpPWpGaD
Bedaquiline—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000145	0.00105	CcSEcCtD
Bedaquiline—Connective tissue disorder—Doxorubicin—prostate cancer	0.000145	0.00105	CcSEcCtD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP7B1—prostate cancer	0.000144	0.00519	CbGpPWpGaD
Bedaquiline—Nausea—Mitoxantrone—prostate cancer	0.000144	0.00105	CcSEcCtD
Bedaquiline—Arrhythmia—Epirubicin—prostate cancer	0.000142	0.00103	CcSEcCtD
Bedaquiline—Nervous system disorder—Prednisone—prostate cancer	0.000142	0.00103	CcSEcCtD
Bedaquiline—CYP3A4—Xenobiotics—CYP1A1—prostate cancer	0.000142	0.00508	CbGpPWpGaD
Bedaquiline—Decreased appetite—Capecitabine—prostate cancer	0.000141	0.00102	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Capecitabine—prostate cancer	0.00014	0.00102	CcSEcCtD
Bedaquiline—Diarrhoea—Etoposide—prostate cancer	0.000138	0.001	CcSEcCtD
Bedaquiline—Anorexia—Prednisone—prostate cancer	0.000138	0.001	CcSEcCtD
Bedaquiline—Cardiac disorder—Doxorubicin—prostate cancer	0.000137	0.000992	CcSEcCtD
Bedaquiline—CYP3A4—Tamoxifen metabolism—CYP1A1—prostate cancer	0.000136	0.00489	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—prostate cancer	0.000135	0.00485	CbGpPWpGaD
Bedaquiline—Dizziness—Etoposide—prostate cancer	0.000134	0.000969	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000132	0.000956	CcSEcCtD
Bedaquiline—Arrhythmia—Doxorubicin—prostate cancer	0.000132	0.000955	CcSEcCtD
Bedaquiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—prostate cancer	0.000129	0.00463	CbGpPWpGaD
Bedaquiline—Vomiting—Etoposide—prostate cancer	0.000129	0.000931	CcSEcCtD
Bedaquiline—Rash—Etoposide—prostate cancer	0.000127	0.000924	CcSEcCtD
Bedaquiline—Dermatitis—Etoposide—prostate cancer	0.000127	0.000923	CcSEcCtD
Bedaquiline—Headache—Etoposide—prostate cancer	0.000127	0.000918	CcSEcCtD
Bedaquiline—Decreased appetite—Prednisone—prostate cancer	0.000126	0.000913	CcSEcCtD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP3A5—prostate cancer	0.000124	0.00445	CbGpPWpGaD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—prostate cancer	0.000122	0.00439	CbGpPWpGaD
Bedaquiline—Diphenhydramine—CYP2C19—prostate cancer	0.000122	0.03	CrCbGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—prostate cancer	0.00012	0.00432	CbGpPWpGaD
Bedaquiline—Nausea—Etoposide—prostate cancer	0.00012	0.00087	CcSEcCtD
Bedaquiline—Tamoxifen—CYP2E1—prostate cancer	0.00012	0.0295	CrCbGaD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—prostate cancer	0.000119	0.00427	CbGpPWpGaD
Bedaquiline—Tamoxifen—CYP2C19—prostate cancer	0.000118	0.0293	CrCbGaD
Bedaquiline—Arthralgia—Epirubicin—prostate cancer	0.000118	0.000857	CcSEcCtD
Bedaquiline—Chest pain—Epirubicin—prostate cancer	0.000118	0.000857	CcSEcCtD
Bedaquiline—Myalgia—Epirubicin—prostate cancer	0.000118	0.000857	CcSEcCtD
Bedaquiline—Tamoxifen—CYP1A1—prostate cancer	0.000118	0.0291	CrCbGaD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	0.000116	0.00418	CbGpPWpGaD
Bedaquiline—Orphenadrine—CYP2E1—prostate cancer	0.000116	0.0287	CrCbGaD
Bedaquiline—Diarrhoea—Docetaxel—prostate cancer	0.000115	0.000833	CcSEcCtD
Bedaquiline—Diarrhoea—Capecitabine—prostate cancer	0.000111	0.000806	CcSEcCtD
Bedaquiline—Nervous system disorder—Epirubicin—prostate cancer	0.000111	0.000805	CcSEcCtD
Bedaquiline—Dizziness—Docetaxel—prostate cancer	0.000111	0.000805	CcSEcCtD
Bedaquiline—CYP3A4—Biological oxidations—UGT2B15—prostate cancer	0.000111	0.00397	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—UGT2B17—prostate cancer	0.000111	0.00397	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—prostate cancer	0.000109	0.00393	CbGpPWpGaD
Bedaquiline—Chest pain—Doxorubicin—prostate cancer	0.000109	0.000793	CcSEcCtD
Bedaquiline—Myalgia—Doxorubicin—prostate cancer	0.000109	0.000793	CcSEcCtD
Bedaquiline—Arthralgia—Doxorubicin—prostate cancer	0.000109	0.000793	CcSEcCtD
Bedaquiline—CYP3A4—Metapathway biotransformation—UGT2B17—prostate cancer	0.000109	0.00392	CbGpPWpGaD
Bedaquiline—Anorexia—Epirubicin—prostate cancer	0.000108	0.000783	CcSEcCtD
Bedaquiline—Dizziness—Capecitabine—prostate cancer	0.000108	0.000779	CcSEcCtD
Bedaquiline—Vomiting—Docetaxel—prostate cancer	0.000107	0.000774	CcSEcCtD
Bedaquiline—Rash—Docetaxel—prostate cancer	0.000106	0.000768	CcSEcCtD
Bedaquiline—Dermatitis—Docetaxel—prostate cancer	0.000106	0.000767	CcSEcCtD
Bedaquiline—Headache—Docetaxel—prostate cancer	0.000105	0.000763	CcSEcCtD
Bedaquiline—CYP3A4—Biological oxidations—GSTM3—prostate cancer	0.000104	0.00374	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—SULT2B1—prostate cancer	0.000104	0.00374	CbGpPWpGaD
Bedaquiline—Vomiting—Capecitabine—prostate cancer	0.000103	0.000749	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000103	0.000748	CcSEcCtD
Bedaquiline—Nervous system disorder—Doxorubicin—prostate cancer	0.000103	0.000745	CcSEcCtD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTM3—prostate cancer	0.000103	0.00369	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—SULT2B1—prostate cancer	0.000103	0.00369	CbGpPWpGaD
Bedaquiline—Rash—Capecitabine—prostate cancer	0.000103	0.000743	CcSEcCtD
Bedaquiline—Dermatitis—Capecitabine—prostate cancer	0.000102	0.000742	CcSEcCtD
Bedaquiline—Headache—Capecitabine—prostate cancer	0.000102	0.000738	CcSEcCtD
Bedaquiline—CYP3A4—Tryptophan metabolism—CYP2E1—prostate cancer	0.000101	0.00363	CbGpPWpGaD
Bedaquiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	0.0001	0.00361	CbGpPWpGaD
Bedaquiline—Anorexia—Doxorubicin—prostate cancer	9.99e-05	0.000724	CcSEcCtD
Bedaquiline—Nausea—Docetaxel—prostate cancer	9.98e-05	0.000723	CcSEcCtD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—prostate cancer	9.97e-05	0.00358	CbGpPWpGaD
Bedaquiline—Diarrhoea—Prednisone—prostate cancer	9.91e-05	0.000718	CcSEcCtD
Bedaquiline—CYP3A4—Biological oxidations—CYP3A43—prostate cancer	9.86e-05	0.00354	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—NAT1—prostate cancer	9.86e-05	0.00354	CbGpPWpGaD
Bedaquiline—Decreased appetite—Epirubicin—prostate cancer	9.85e-05	0.000714	CcSEcCtD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—prostate cancer	9.84e-05	0.00353	CbGpPWpGaD
Bedaquiline—Gastrointestinal disorder—Epirubicin—prostate cancer	9.78e-05	0.000709	CcSEcCtD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—prostate cancer	9.75e-05	0.0035	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP3A43—prostate cancer	9.73e-05	0.00349	CbGpPWpGaD
Bedaquiline—Nausea—Capecitabine—prostate cancer	9.66e-05	0.0007	CcSEcCtD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—prostate cancer	9.62e-05	0.00346	CbGpPWpGaD
Bedaquiline—CYP3A4—Tryptophan metabolism—CYP1B1—prostate cancer	9.59e-05	0.00344	CbGpPWpGaD
Bedaquiline—Dizziness—Prednisone—prostate cancer	9.58e-05	0.000694	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Doxorubicin—prostate cancer	9.55e-05	0.000692	CcSEcCtD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—prostate cancer	9.49e-05	0.00341	CbGpPWpGaD
Bedaquiline—Vomiting—Prednisone—prostate cancer	9.21e-05	0.000667	CcSEcCtD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—prostate cancer	9.21e-05	0.00331	CbGpPWpGaD
Bedaquiline—Rash—Prednisone—prostate cancer	9.14e-05	0.000662	CcSEcCtD
Bedaquiline—Dermatitis—Prednisone—prostate cancer	9.13e-05	0.000661	CcSEcCtD
Bedaquiline—Decreased appetite—Doxorubicin—prostate cancer	9.11e-05	0.00066	CcSEcCtD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—prostate cancer	9.09e-05	0.00327	CbGpPWpGaD
Bedaquiline—Headache—Prednisone—prostate cancer	9.08e-05	0.000658	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Doxorubicin—prostate cancer	9.05e-05	0.000656	CcSEcCtD
Bedaquiline—CYP3A4—Tryptophan metabolism—CYP19A1—prostate cancer	9.02e-05	0.00324	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—prostate cancer	8.78e-05	0.00315	CbGpPWpGaD
Bedaquiline—Nausea—Prednisone—prostate cancer	8.61e-05	0.000624	CcSEcCtD
Bedaquiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	8.47e-05	0.00304	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—EPHX1—prostate cancer	8.27e-05	0.00297	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—prostate cancer	8.18e-05	0.00294	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—prostate cancer	8.08e-05	0.0029	CbGpPWpGaD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—prostate cancer	8.07e-05	0.0029	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—prostate cancer	7.8e-05	0.0028	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—prostate cancer	7.75e-05	0.00278	CbGpPWpGaD
Bedaquiline—Diarrhoea—Epirubicin—prostate cancer	7.75e-05	0.000562	CcSEcCtD
Bedaquiline—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	7.67e-05	0.00276	CbGpPWpGaD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	7.65e-05	0.00275	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	7.57e-05	0.00272	CbGpPWpGaD
Bedaquiline—Tamoxifen—CYP3A4—prostate cancer	7.53e-05	0.0186	CrCbGaD
Bedaquiline—Dizziness—Epirubicin—prostate cancer	7.49e-05	0.000543	CcSEcCtD
Bedaquiline—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	7.48e-05	0.00268	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	7.47e-05	0.00268	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	7.4e-05	0.00266	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	7.37e-05	0.00265	CbGpPWpGaD
Bedaquiline—Orphenadrine—CYP3A4—prostate cancer	7.31e-05	0.0181	CrCbGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	7.29e-05	0.00262	CbGpPWpGaD
Bedaquiline—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	7.27e-05	0.00261	CbGpPWpGaD
Bedaquiline—Vomiting—Epirubicin—prostate cancer	7.21e-05	0.000522	CcSEcCtD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	7.19e-05	0.00258	CbGpPWpGaD
Bedaquiline—Diarrhoea—Doxorubicin—prostate cancer	7.17e-05	0.00052	CcSEcCtD
Bedaquiline—Rash—Epirubicin—prostate cancer	7.15e-05	0.000518	CcSEcCtD
Bedaquiline—Dermatitis—Epirubicin—prostate cancer	7.14e-05	0.000517	CcSEcCtD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	7.12e-05	0.00256	CbGpPWpGaD
Bedaquiline—Headache—Epirubicin—prostate cancer	7.1e-05	0.000514	CcSEcCtD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	7.04e-05	0.00253	CbGpPWpGaD
Bedaquiline—Dizziness—Doxorubicin—prostate cancer	6.93e-05	0.000502	CcSEcCtD
Bedaquiline—Nausea—Epirubicin—prostate cancer	6.73e-05	0.000488	CcSEcCtD
Bedaquiline—Vomiting—Doxorubicin—prostate cancer	6.67e-05	0.000483	CcSEcCtD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	6.63e-05	0.00238	CbGpPWpGaD
Bedaquiline—Rash—Doxorubicin—prostate cancer	6.61e-05	0.000479	CcSEcCtD
Bedaquiline—Dermatitis—Doxorubicin—prostate cancer	6.61e-05	0.000479	CcSEcCtD
Bedaquiline—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	6.58e-05	0.00236	CbGpPWpGaD
Bedaquiline—Headache—Doxorubicin—prostate cancer	6.57e-05	0.000476	CcSEcCtD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	6.49e-05	0.00233	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTA3—prostate cancer	6.36e-05	0.00228	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	6.29e-05	0.00226	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	6.27e-05	0.00225	CbGpPWpGaD
Bedaquiline—Nausea—Doxorubicin—prostate cancer	6.23e-05	0.000451	CcSEcCtD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	6e-05	0.00215	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	5.91e-05	0.00212	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	5.88e-05	0.00211	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTA4—prostate cancer	5.81e-05	0.00209	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	5.81e-05	0.00209	CbGpPWpGaD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	5.8e-05	0.00208	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	5.73e-05	0.00206	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	5.7e-05	0.00205	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTA2—prostate cancer	5.67e-05	0.00203	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	5.6e-05	0.00201	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	5.52e-05	0.00198	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTA1—prostate cancer	5.47e-05	0.00196	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTO1—prostate cancer	5.4e-05	0.00194	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—NAT2—prostate cancer	5.4e-05	0.00194	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	5.33e-05	0.00191	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	5.33e-05	0.00191	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	5.18e-05	0.00186	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	5.11e-05	0.00184	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	4.82e-05	0.00173	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	4.76e-05	0.00171	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	4.75e-05	0.00171	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	4.53e-05	0.00163	CbGpPWpGaD
Bedaquiline—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	4.48e-05	0.00161	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—HPGDS—prostate cancer	4.32e-05	0.00155	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	4.29e-05	0.00154	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	4.23e-05	0.00152	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTT1—prostate cancer	4.19e-05	0.00151	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	4.14e-05	0.00149	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	3.97e-05	0.00143	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	3.97e-05	0.00142	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	3.91e-05	0.00141	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—NCOA2—prostate cancer	3.78e-05	0.00136	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	3.52e-05	0.00127	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	3.47e-05	0.00125	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	3.34e-05	0.0012	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	3.29e-05	0.00118	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GGT1—prostate cancer	3.23e-05	0.00116	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—NCOA1—prostate cancer	3.19e-05	0.00114	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	3.14e-05	0.00113	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	3.1e-05	0.00111	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—RXRA—prostate cancer	3.03e-05	0.00109	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—COMT—prostate cancer	2.92e-05	0.00105	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.9e-05	0.00104	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.88e-05	0.00103	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.86e-05	0.00103	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTM1—prostate cancer	2.67e-05	0.000959	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	2.63e-05	0.000946	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.53e-05	0.000909	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—HAO1—prostate cancer	2.5e-05	0.000897	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.5e-05	0.000896	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GRHL1—prostate cancer	2.04e-05	0.000731	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PSAT1—prostate cancer	2.04e-05	0.000731	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CSAD—prostate cancer	2.04e-05	0.000731	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ADI1—prostate cancer	2.04e-05	0.000731	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—TST—prostate cancer	2.04e-05	0.000731	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CBR1—prostate cancer	2.04e-05	0.000731	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GRHPR—prostate cancer	1.89e-05	0.00068	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.89e-05	0.00068	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.89e-05	0.00068	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CKMT2—prostate cancer	1.89e-05	0.00068	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.78e-05	0.000639	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.78e-05	0.000639	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—NAGLU—prostate cancer	1.78e-05	0.000639	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—RFK—prostate cancer	1.78e-05	0.000639	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PGAM2—prostate cancer	1.78e-05	0.000639	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—AOX1—prostate cancer	1.78e-05	0.000639	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTM3—prostate cancer	1.78e-05	0.000639	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.69e-05	0.000606	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—AMACR—prostate cancer	1.69e-05	0.000606	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—DEGS1—prostate cancer	1.69e-05	0.000606	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.69e-05	0.000606	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—NAT1—prostate cancer	1.69e-05	0.000606	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.61e-05	0.000578	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—HPGD—prostate cancer	1.43e-05	0.000515	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.43e-05	0.000515	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.35e-05	0.000484	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.31e-05	0.000471	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—MTAP—prostate cancer	1.31e-05	0.000471	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.28e-05	0.000459	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.28e-05	0.000459	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.22e-05	0.000438	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ACSL4—prostate cancer	1.22e-05	0.000438	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—UMPS—prostate cancer	1.17e-05	0.00042	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ARG2—prostate cancer	1.17e-05	0.00042	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PHGDH—prostate cancer	1.17e-05	0.00042	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—LDHB—prostate cancer	1.15e-05	0.000412	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.13e-05	0.000404	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTA3—prostate cancer	1.09e-05	0.00039	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PDHA1—prostate cancer	1.09e-05	0.00039	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—TCN2—prostate cancer	1.09e-05	0.00039	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—UCP3—prostate cancer	1.09e-05	0.00039	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.04e-05	0.000372	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.04e-05	0.000372	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—TBXAS1—prostate cancer	9.94e-06	0.000357	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTA4—prostate cancer	9.94e-06	0.000357	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTA2—prostate cancer	9.69e-06	0.000348	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ABCG5—prostate cancer	9.57e-06	0.000344	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—SULT1A1—prostate cancer	9.57e-06	0.000344	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTA1—prostate cancer	9.35e-06	0.000336	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTO1—prostate cancer	9.24e-06	0.000332	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—HSD3B2—prostate cancer	9.24e-06	0.000332	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—NAT2—prostate cancer	9.24e-06	0.000332	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PLCB2—prostate cancer	8.86e-06	0.000318	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP2C18—prostate cancer	8.86e-06	0.000318	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—LRP2—prostate cancer	8.86e-06	0.000318	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—P4HB—prostate cancer	8.69e-06	0.000312	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—SLC22A1—prostate cancer	8.45e-06	0.000304	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—SULT2A1—prostate cancer	8.24e-06	0.000296	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—MED12—prostate cancer	8.1e-06	0.000291	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GNG5—prostate cancer	8.04e-06	0.000289	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—NCOA3—prostate cancer	7.75e-06	0.000278	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—HPGDS—prostate cancer	7.39e-06	0.000265	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP2C19—prostate cancer	7.34e-06	0.000264	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ACHE—prostate cancer	7.17e-06	0.000257	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTT1—prostate cancer	7.17e-06	0.000257	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP2A6—prostate cancer	7.08e-06	0.000254	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.89e-06	0.000248	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PRKACB—prostate cancer	6.85e-06	0.000246	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.78e-06	0.000244	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—NCOA2—prostate cancer	6.46e-06	0.000232	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—SLC5A5—prostate cancer	6.17e-06	0.000221	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP2E1—prostate cancer	6.02e-06	0.000216	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—NQO1—prostate cancer	5.96e-06	0.000214	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—TH—prostate cancer	5.87e-06	0.000211	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.71e-06	0.000205	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GGT1—prostate cancer	5.53e-06	0.000199	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—NCOA1—prostate cancer	5.45e-06	0.000196	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.37e-06	0.000193	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—RXRA—prostate cancer	5.18e-06	0.000186	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—COMT—prostate cancer	4.99e-06	0.000179	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTP1—prostate cancer	4.97e-06	0.000178	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ITPR1—prostate cancer	4.89e-06	0.000176	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—TYMS—prostate cancer	4.62e-06	0.000166	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTM1—prostate cancer	4.57e-06	0.000164	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—LPL—prostate cancer	4.48e-06	0.000161	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.33e-06	0.000155	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ERCC2—prostate cancer	4.29e-06	0.000154	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—MTHFR—prostate cancer	4.03e-06	0.000145	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PPARA—prostate cancer	3.96e-06	0.000142	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CAV1—prostate cancer	3.72e-06	0.000134	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.39e-06	0.000122	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—INS—prostate cancer	3.21e-06	0.000115	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CREBBP—prostate cancer	3.14e-06	0.000113	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.98e-06	0.000107	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—NOS3—prostate cancer	2.81e-06	0.000101	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.6e-06	9.33e-05	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PTGS2—prostate cancer	2.57e-06	9.24e-05	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PTEN—prostate cancer	2.24e-06	8.06e-05	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—EP300—prostate cancer	2.14e-06	7.69e-05	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.58e-06	5.69e-05	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—AKT1—prostate cancer	1.29e-06	4.65e-05	CbGpPWpGaD
